Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
Closed Posted
- Opportunity number
- RFA-HG-20-014
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $700,000
Opportunity facts
- Assistance listings
-
- 93.172 Human Genome Research
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Tribal Governments (Federally Recognized)
- Special District Governments
- 501(c)(3) Nonprofits
- For Profit Organizations
- Small Businesses
- Public or Indian Housing Auth.
- Higher Education Inst. (Public)
- County Governments
- Tribal Organizations (Not Federally Recognized)
- City/Township Governments
- Independent School Districts
- Higher Education Inst. (Private)
- Non-501(c)(3) Nonprofits
- State Governments
- Other
- Full announcement
Opportunity details come from Grants.gov. Updated .
Synopsis
This Funding Opportunity Announcement (FOA) solicits R01 grant applications to develop novel technologies that will enable no less than one order of magnitude improvement in synthetic nucleic acids. The goal is to improve the quality, capabilities and efficiency of nucleic acid synthesis and synthetic constructs (e.g., longer oligonucleotide and synthetic construct lengths, faster turn-around times, greater accuracy, incorporation of modified bases, higher-throughput, etc.) at reasonable and decreased costs with the anticipation that major advances in any of these and related areas would make significant contributions to the mission of NIH, NHGRI and the field of genomics, including to many of NHGRIs other technology development goals.
Files
| File | Type | Posted |
|---|---|---|
| RFA-HG-20-014-Full-Announcement.html | HTML file | |
| PKG00260235-instructions.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity